These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12200190)

  • 1. N-methylation underlying Parkinson's disease.
    Matsubara K; Aoyama K; Suno M; Awaya T
    Neurotoxicol Teratol; 2002; 24(5):593-8. PubMed ID: 12200190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test.
    Aoyama K; Matsubara K; Okada K; Fukushima S; Shimizu K; Yamaguchi S; Uezono T; Satomi M; Hayase N; Ohta S; Shiono H; Kobayashi S
    J Neural Transm (Vienna); 2000; 107(8-9):985-95. PubMed ID: 11041277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K
    Nihon Hoigaku Zasshi; 1998 Oct; 52(5):301-5. PubMed ID: 10077975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease.
    Aoyama K; Matsubara K; Kondo M; Murakawa Y; Suno M; Yamashita K; Yamaguchi S; Kobayashi S
    Neurosci Lett; 2001 Jan; 298(1):78-80. PubMed ID: 11154840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amine-related neurotoxins in Parkinson's disease: past, present, and future.
    Nagatsu T
    Neurotoxicol Teratol; 2002; 24(5):565-9. PubMed ID: 12200187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 8. Type B monoamine oxidase and neurotoxins.
    Naoi M; Maruyama W
    Eur Neurol; 1993; 33 Suppl 1():31-7. PubMed ID: 8375430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of idiopathic Parkinson's disease].
    Maruyama W
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyltetrahydropyridines and pyridinium cations as toxins and comparison with naturally-occurring alkaloids.
    Herraiz T
    Food Chem Toxicol; 2016 Nov; 97():23-39. PubMed ID: 27523294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
    Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain.
    Parsons RB; Smith ML; Williams AC; Waring RH; Ramsden DB
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):111-24. PubMed ID: 11853016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoquinoline neurotoxins in the brain and Parkinson's disease.
    Nagatsu T
    Neurosci Res; 1997 Oct; 29(2):99-111. PubMed ID: 9359458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
    Naoi M; Maruyama W; Niwa T; Nagatsu T
    J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL; Jones K; Hansen S; Wall RA
    Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.